Relative effects of two different enoxaparin regimens as comparators against newer oral anticoagulants: meta-analysis and adjusted indirect comparison

Chun Shing Kwok, Shiva Pradhan, Jessica Ka-yan Yeong, Yoon K Loke

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)


Two different regimens of enoxaparin (40 mg once daily or 30 mg bid) have been used as control arms in trials of new oral anticoagulants. The choice of enoxaparin comparator may influence the perceived relative efficacy and safety of the newer agents, and we aimed to identify any significant differences between the two enoxaparin regimens.
Original languageEnglish
Pages (from-to)593-600
Number of pages8
Issue number2
Publication statusPublished - Aug 2013


  • Administration, Oral
  • Anticoagulants
  • Arthroplasty, Replacement, Hip
  • Arthroplasty, Replacement, Knee
  • Benzimidazoles
  • Enoxaparin
  • Humans
  • Morpholines
  • Pyrazoles
  • Pyridones
  • Randomized Controlled Trials as Topic
  • Thiophenes
  • Venous Thromboembolism
  • beta-Alanine

Cite this